Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
FLGC 
Flora Growth Corp (FLGC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: FLGC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
2 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $93
1 Year Target Price $93
| 1 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -89.38% | Avg. Invested days 19 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 16.15M USD | Price to earnings Ratio - | 1Y Target Price 93 |
Price to earnings Ratio - | 1Y Target Price 93 | ||
Volume (30-day avg) 2 | Beta 1.96 | 52 Weeks Range 15.15 - 82.29 | Updated Date 09/17/2025 |
52 Weeks Range 15.15 - 82.29 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -34.71 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -24.96% | Operating Margin (TTM) -17.34% |
Management Effectiveness
Return on Assets (TTM) -30.57% | Return on Equity (TTM) -212.2% |
Valuation
Trailing PE - | Forward PE 7.89 | Enterprise Value 22448255 | Price to Sales(TTM) 0.31 |
Enterprise Value 22448255 | Price to Sales(TTM) 0.31 | ||
Enterprise Value to Revenue 0.43 | Enterprise Value to EBITDA -1 | Shares Outstanding 578683 | Shares Floating 506438 |
Shares Outstanding 578683 | Shares Floating 506438 | ||
Percent Insiders 12.54 | Percent Institutions 4.08 |
Upturn AI SWOT
Flora Growth Corp
Company Overview
History and Background
Flora Growth Corp. was founded in 2019, initially focusing on the cultivation and distribution of cannabis products, and has since expanded into multiple consumer packaged goods categories.
Core Business Areas
- Flora Pharma: Focuses on manufacturing and distributing pharmaceutical-grade cannabis products.
- Flora Beauty: Develops and markets beauty and skincare products infused with cannabis-derived ingredients.
- Flora Food: Produces and sells food and beverage products infused with cannabis-derived ingredients and plant based products.
Leadership and Structure
Flora Growth Corp's leadership team includes Luis Merchan (Chairman & CEO) and other key executives overseeing various departments. The organizational structure consists of distinct divisions focused on pharma, beauty, and food sectors.
Top Products and Market Share
Key Offerings
- Mind Naturals: A skincare line utilizing CBD. Market share and revenue figures are not readily available. Competitors include Charlotte's Web and CBDfx.
- JustCBD: A brand of CBD edibles and other CBD products. Market share and revenue figures are not readily available. Competitors include CV Sciences and cbdMD.
- KOA: Plant based nutritional products with minimal market share reported. Competitors include Beyond Meat and Impossible Foods.
Market Dynamics
Industry Overview
The industry is characterized by rapidly evolving regulations, increasing consumer acceptance of cannabis-related products, and intense competition.
Positioning
Flora Growth Corp aims to establish a vertically integrated presence across the cannabis value chain, focusing on emerging markets and strategic partnerships.
Total Addressable Market (TAM)
The global legal cannabis market is expected to reach hundreds of billions of USD in the coming years. Flora is positioned to capture market share via product line and emerging market penetration.
Upturn SWOT Analysis
Strengths
- Vertically integrated operations
- Diversified product portfolio
- Presence in emerging markets
- Strategic partnerships
Weaknesses
- Limited brand recognition
- Dependence on regulatory changes
- Negative Cash Flow
Opportunities
- Expansion into new geographic markets
- Product innovation
- Strategic acquisitions
- Regulatory liberalization
Threats
- Intense competition
- Regulatory uncertainty
- Price volatility of cannabis
- Fluctuations in consumer demand
Competitors and Market Share
Key Competitors
- Canopy Growth Corporation (CGC)
- Tilray Brands, Inc. (TLRY)
- Curaleaf Holdings, Inc. (CURLF)
Competitive Landscape
Flora Growth faces stiff competition from larger, more established players with greater resources and brand recognition. Differentiation through product innovation and strategic market penetration are crucial.
Major Acquisitions
JustCBD
- Year: 2022
- Acquisition Price (USD millions): 33.7
- Strategic Rationale: Expansion into the US market and diversification of product offerings in the CBD sector.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are challenging to determine due to limited operating history and fluctuating market conditions.
Future Projections: Future projections are dependent on market conditions and regulatory approvals, requiring further investigation.
Recent Initiatives: Recent initiatives include expanding product lines and forming strategic partnerships.
Summary
Flora Growth Corp is a relatively young company attempting to establish a presence in the competitive cannabis and consumer packaged goods markets. While its diversified strategy and presence in emerging markets offer potential, it faces challenges related to brand recognition, regulatory uncertainty, and competition from larger players. Recent acquisitions and strategic initiatives aim to drive future growth. Its future success is based on whether it can achieve positive cashflow and revenue growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Public News Sources
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market conditions and company performance can change rapidly. Please consult with a financial professional before making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Flora Growth Corp
Exchange NASDAQ | Headquaters Fort Lauderdale, FL, United States | ||
IPO Launch date 2021-05-11 | CEO & Director Mr. Clifford A. Starke | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 64 | Website https://www.floragrowth.com |
Full time employees 64 | Website https://www.floragrowth.com | ||
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. The company operates in three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. It cultivates, processes, and supplies medicinal-grade cannabis flower, as well as cannabis derived medical and wellness products. The company also offers food and beverage, nutraceutical, cannabis accessories and technology, personal care, and wellness products; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; and cannabis consumption accessories, as well as personal storage and travel accessories for the vape and dry herbs. In addition, it manufactures and distributes pharmaceutical goods and medical cannabis products to treat a range of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brand names. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.